352 related articles for article (PubMed ID: 2295804)
1. Bactericidal/permeability-increasing protein has endotoxin-neutralizing activity.
Marra MN; Wilde CG; Griffith JE; Snable JL; Scott RW
J Immunol; 1990 Jan; 144(2):662-6. PubMed ID: 2295804
[TBL] [Abstract][Full Text] [Related]
2. Antibacterial proteins of granulocytes differ in interaction with endotoxin. Comparison of bactericidal/permeability-increasing protein, p15s, and defensins.
Levy O; Ooi CE; Elsbach P; Doerfler ME; Lehrer RI; Weiss J
J Immunol; 1995 May; 154(10):5403-10. PubMed ID: 7730641
[TBL] [Abstract][Full Text] [Related]
3. The role of bactericidal/permeability-increasing protein as a natural inhibitor of bacterial endotoxin.
Marra MN; Wilde CG; Collins MS; Snable JL; Thornton MB; Scott RW
J Immunol; 1992 Jan; 148(2):532-7. PubMed ID: 1729370
[TBL] [Abstract][Full Text] [Related]
4. The bactericidal/permeability increasing protein of neutrophils is a potent antibacterial and anti-endotoxin agent in vitro and in vivo.
Elsbach P; Weiss J; Doerfler M; Shu C; Kohn F; Ammons WS; Kung AH; Meszaros KK; Parent JB
Prog Clin Biol Res; 1994; 388():41-51. PubMed ID: 7831373
[TBL] [Abstract][Full Text] [Related]
5. A synthetic peptide derived from bactericidal/permeability-increasing protein neutralizes endotoxin in vitro and in vivo.
Jiang Z; Hong Z; Guo W; Xiaoyun G; Gengfa L; Yongning L; Guangxia X
Int Immunopharmacol; 2004 Apr; 4(4):527-37. PubMed ID: 15099530
[TBL] [Abstract][Full Text] [Related]
6. A peptide derived from human bactericidal/permeability-increasing protein (BPI) exerts bactericidal activity against Gram-negative bacterial isolates obtained from clinical cases of bovine mastitis.
Chockalingam A; McKinney CE; Rinaldi M; Zarlenga DS; Bannerman DD
Vet Microbiol; 2007 Nov; 125(1-2):80-90. PubMed ID: 17560054
[TBL] [Abstract][Full Text] [Related]
7. The role of lipopolysaccharides in the action of the bactericidal/permeability-increasing neutrophil protein on the bacterial envelope.
Weiss J; Muello K; Victor M; Elsbach P
J Immunol; 1984 Jun; 132(6):3109-15. PubMed ID: 6373924
[TBL] [Abstract][Full Text] [Related]
8. Endotoxin-neutralizing properties of the 25 kD N-terminal fragment and a newly isolated 30 kD C-terminal fragment of the 55-60 kD bactericidal/permeability-increasing protein of human neutrophils.
Ooi CE; Weiss J; Doerfler ME; Elsbach P
J Exp Med; 1991 Sep; 174(3):649-55. PubMed ID: 1875165
[TBL] [Abstract][Full Text] [Related]
9. [A study on bactericidal/permeability increasing protein (BPI) as a natural inhibitor of endotoxin].
Zhou H
Zhonghua Shao Shang Za Zhi; 2001 Apr; 17(2):102-4. PubMed ID: 11876922
[TBL] [Abstract][Full Text] [Related]
10. Human granulocytes express a 55-kDa lipopolysaccharide-binding protein on the cell surface that is identical to the bactericidal/permeability-increasing protein.
Weersink AJ; van Kessel KP; van den Tol ME; van Strijp JA; Torensma R; Verhoef J; Elsbach P; Weiss J
J Immunol; 1993 Jan; 150(1):253-63. PubMed ID: 7678030
[TBL] [Abstract][Full Text] [Related]
11. A novel endotoxin antagonist attenuates tumor necrosis factor-alpha secretion.
Dahlberg PS; Acton RD; Battafarano RJ; Uknis ME; Ratz CA; Johnston JW; Haseman JR; Gray BH; Dunn DL
J Surg Res; 1996 Jun; 63(1):44-8. PubMed ID: 8661170
[TBL] [Abstract][Full Text] [Related]
12. Preferential binding of the neutrophil cytoplasmic granule-derived bactericidal/permeability increasing protein to target bacteria. Implications and use as a means of purification.
Mannion BA; Kalatzis ES; Weiss J; Elsbach P
J Immunol; 1989 Apr; 142(8):2807-12. PubMed ID: 2539411
[TBL] [Abstract][Full Text] [Related]
13. The bactericidal/permeability-increasing protein (BPI), a potent element in host-defense against gram-negative bacteria and lipopolysaccharide.
Elsbach P; Weiss J
Immunobiology; 1993 Apr; 187(3-5):417-29. PubMed ID: 8330906
[TBL] [Abstract][Full Text] [Related]
14. Lipopolysaccharide LPS-mediated soluble TNF receptor release and TNF receptor expression by monocytes. Role of CD14, LPS binding protein, and bactericidal/permeability-increasing protein.
Leeuwenberg JF; Dentener MA; Buurman WA
J Immunol; 1994 May; 152(10):5070-6. PubMed ID: 7513728
[TBL] [Abstract][Full Text] [Related]
15. Human bactericidal/permeability-increasing protein and a recombinant NH2-terminal fragment cause killing of serum-resistant gram-negative bacteria in whole blood and inhibit tumor necrosis factor release induced by the bacteria.
Weiss J; Elsbach P; Shu C; Castillo J; Grinna L; Horwitz A; Theofan G
J Clin Invest; 1992 Sep; 90(3):1122-30. PubMed ID: 1522221
[TBL] [Abstract][Full Text] [Related]
16. Release of bactericidal/permeability-increasing protein in experimental endotoxemia and clinical sepsis. Role of tumor necrosis factor.
von der Möhlen MA; van der Poll T; Jansen J; Levi M; van Deventer SJ
J Immunol; 1996 Jun; 156(12):4969-73. PubMed ID: 8648149
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of lipid A-mediated type I interferon induction by bactericidal/permeability-increasing protein (BPI).
Azuma M; Matsuo A; Fujimoto Y; Fukase K; Hazeki K; Hazeki O; Matsumoto M; Seya T
Biochem Biophys Res Commun; 2007 Mar; 354(2):574-8. PubMed ID: 17239348
[TBL] [Abstract][Full Text] [Related]
18. Structure/function studies of an endotoxin-neutralizing peptide derived from bactericidal/permeability-increasing protein.
Wasiluk KR; Leslie DB; Vietzen PS; Mayo KH; Dunn DL
Surgery; 2004 Aug; 136(2):253-60. PubMed ID: 15300188
[TBL] [Abstract][Full Text] [Related]
19. Antimicrobial activity of bovine bactericidal permeability-increasing protein-derived peptides against gram-negative bacteria isolated from the milk of cows with clinical mastitis.
Chockalingam A; Zarlenga DS; Bannerman DD
Am J Vet Res; 2007 Nov; 68(11):1151-9. PubMed ID: 17975968
[TBL] [Abstract][Full Text] [Related]
20. Antagonistic effects of lipopolysaccharide binding protein and bactericidal/permeability-increasing protein on lipopolysaccharide-induced cytokine release by mononuclear phagocytes. Competition for binding to lipopolysaccharide.
Dentener MA; Von Asmuth EJ; Francot GJ; Marra MN; Buurman WA
J Immunol; 1993 Oct; 151(8):4258-65. PubMed ID: 8409400
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
